Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active...
Reexamination Certificate
2004-04-26
2011-11-01
Fubara, Blessing (Department: 1613)
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
C424S009400, C424S078310, C424S078370
Reexamination Certificate
active
08048407
ABSTRACT:
A method and composition for treating arteriovenous malformations (AVMs), or abnormal vasculature in the body are provided. The method comprises introducing into the region of an AVM a composition comprising a nucleophilic component, such as a thiol, and a component containing a conjugated unsaturated bond, such as an acrylate through a catheter, whereby the composition crosslinks within the body to block or occlude the AVM.
REFERENCES:
patent: 4881825 (1989-11-01), Olesen
patent: 4978619 (1990-12-01), Kajiwara et al.
patent: 5356432 (1994-10-01), Rutkow et al.
patent: 5514379 (1996-05-01), Weissleder et al.
patent: 5667767 (1997-09-01), Greff et al.
patent: 5823198 (1998-10-01), Jones et al.
patent: 6066325 (2000-05-01), Wallace et al.
patent: 6096021 (2000-08-01), Helm et al.
patent: 6113629 (2000-09-01), Ken
patent: 6152943 (2000-11-01), Sawhney
patent: 6165193 (2000-12-01), Greene, Jr. et al.
patent: 6245090 (2001-06-01), Gilson et al.
patent: 6299619 (2001-10-01), Greene, Jr. et al.
patent: 6312421 (2001-11-01), Boock
patent: 6342202 (2002-01-01), Evans et al.
patent: 6428576 (2002-08-01), Haldimann
patent: 6463317 (2002-10-01), Kuckarczyk et al.
patent: 6475516 (2002-11-01), DiCosmo et al.
patent: 6645167 (2003-11-01), Whalen et al.
patent: WO2004/096152 (2004-11-01), None
Vernon et al. (“Water-borne, in situ cross-linked biomaterials from phase-segregated precursors,” in J. Biomed. Material Res., Mar. 1, 2003, 64(3), pp. 447-456).
Verduyn Lunel (“Significance of annulus fibrosus of heart in relation to AV conduction and ventricular activation in cases of Wolff-Parkinson-White syndrome,” in British Heart Journal, 1972, 34, 1263-1271).
Becker, T. et al., Calcium Alginate Gel: A biocompatible and mechanically stable polymer for endovascular treatment. Journal of Biomedical Materials Research, vol. 54 (2001), pp. 76-86.
Becker, T. et al., Flow properties of liquid calcium alginate polymer injected through medical microcatheters for endovascular embolization. Journal of Biomedical Materials Research, accepted Dec. 19, 2001, pp. 533-540.
Hillman, J., Population-based analysis of arteriovenous malformation treatment. J. Neurosurg. Oct. 2001: 95(4):633-637.
Irie, K. et al., Treatment of arteriovenous malformation of the brain—preliminary experience. J. Clin. Neurosci. Sep. 2000; 7 Supple 1:24-29.
Jizong, Z., et al., Combination of intraoperative embolisation with surgical resection for treatment of giant cerebal arteriovenous malformations. J. Clin. Neurosci. Sep. 2000; 7 Suppl. 1:54-59.
Li, Xiaowei, et al., ThermosensitiveN-isopropylacrylamide—N-propylacrylamide-vinyl pyrrolidone terpolymers: Synthesis, characterization and preliminary application as embolic agents. J. Biomaterials 2005.05.094.
Liu, H.M., et al., Embolization of cerebral arteriovenous malformations with n-butyl-2-cyanoacrylate. J. Formos.Med. Addoc. Dec. 2000: 99(12):906-913.
Soga, Youji, M.D., et al., Calcium Alginate Provides a High ° of Embolization in Aneurysm Models: A Specific Comparison to Coil Packing, Neurosurgery, vol. 55, No. 6, Dec. 2004, pp. 1401-1409.
Vernon, B. et al., Water-borne, in-situ Cross-Linked Biomaterials from Phase Segregated Precursors, 2003 Wiley Periodicals, Inc. J Biomed Mater Res 64A: 447-456, 2003.
Wallace, R. et al., Brain Arteriovenous Malformations. Neuroimaging Clin. N. America. May 1998; 8(2): 383-99.
Wallace, R. et al., The Safety and Effectiveness of Brain AVM Embolization using Acrylic and Particles: The Experience of a Single Institution, Neurosurgery. Oct. 1995; 37(4): 606-18.
Wuyts FL, Vanhuyse VJ, Langewouters GJ, Decraemer WF, Raman ER, Buyle S. Elastic properties of human aortas in relation to age and atherosclerosis: a structural model. Phys Med Biol. Oct. 1995; 40(10):1577-97.
Zhao, Chengru, et al., A new thermosensitive polymer as nonadhesive liquid embolism material, Current Applied Physics, 5 (2005), 497-500.
Birdno Merrill
Preul Mark C.
Vernon Brent
Fubara Blessing
Maschoff Gilmore & Israelsen
LandOfFree
In situ gelling self-reactive materials for embolization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In situ gelling self-reactive materials for embolization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In situ gelling self-reactive materials for embolization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4254680